Complications of Antiphospholipid Syndrome – APS Awareness Month Day 1 – APS Foundation of America
APS Foundation of America shared a post on LinkedIn:
“Complications of Antiphospholipid Syndrome – APS Awareness Month Day 1
Antiphospholipid syndrome (APS) can lead to several serious complications that significantly impact health.
One of the most notable complications is the increased risk of thrombosis, which can occur in both arteries and veins.
This leads to conditions like deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke. Pregnant women with APS face heightened risks, including recurrent miscarriages, preterm birth, and placental issues, which can affect both mother and baby.
Moreover, APS can cause complications such as heart valve problems, known as Libman-Sacks endocarditis, which might lead to heart failure if untreated. Additionally, some individuals may develop neurological issues, including memory problems or dementia, due to reduced blood flow to the brain.
Managing APS is crucial, often involving blood thinners to prevent clot formation. Regular check-ups and working closely with healthcare providers can help mitigate these risks and improve quality of life.
If you have any questions or concerns about APS, don’t hesitate to reach out for more information or support.”
Stay updated with Hemostasis Today.
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH
-
Sep 18, 2026, 15:54Swapnil Pawar: Why Aren’t We Using Cryopreserved Platelets Everywhere Yet?
-
Sep 18, 2026, 15:37Abdul Mannan: Evaluating Longitudinal Platelet Trends Beyond Standard Reference Intervals
-
Sep 18, 2026, 15:30Peter A. Everts։ Platelet Phenotype May Hold the Key to More Consistent PRP Therapy
-
Sep 18, 2026, 15:25Brandon Temple: Turning Personal Experience Into Advocacy for wAIHA Research